Daewoong Co., Ltd - 24 Mar 2025 SCHEDULE 13D/A Report for AEON Biopharma, Inc. Common Stock, $0.0001 par value per share

Filing Manager
Daewoong Co., Ltd
Reporting Manager
Daewoong Co.,Ltd. ("DWC")
Security
AEON Biopharma, Inc. Common Stock, $0.0001 par value per share
Shares outstanding
10,150,778 shares
Disclosed Ownership
91,357 shares
Ownership
0.9%
Form type
SCHEDULE 13D/A
Filing time
29 Jan 2026, 21:03:56 UTC
Date of event
24 Mar 2025
Next filing
29 Jan 2026
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Daewoong Co.,Ltd. ("DWC") 0.9% 91,357 58,023 91,357 /s/ Kyu Sung Lim Kyu Sung Lim/Authorized Signatory of Daewoong Co., Ltd. 0001985493
Daewoong Pharmaceutical Co. Ltd ("DWP") 0.3% 33,334 33,334 0 /s/ Woo Hyun Kim Woo Hyun Kim/Authorized Signatory of Daewoong Pharmaceutical Co., Ltd.